Approaches to the emerging business of cannabis products seem to change on a daily basis: Legal? Illegal? Beneficial? Harmful? This webinar will provide an overview of the current state of cannabis regulation. We will first discuss scientific definitions of various cannabis-derived substances, including CBD, THC, and hemp, and the pharmacology of how these substances can affect the body. Our experts will then provide updates to various federal agencies’ regulation of cannabis products, as well as implications for companies operating in states that have legalized cannabis for medical and/or recreational purposes. Finally, we will provide an update on international governing bodies’ approaches to cannabis regulation.
- +$100 for nonmembers
William Garvin, Shareholder, Buchanan Ingersoll & Rooney PC
Aidan Hampson, Special Content Expert Cannabis, NIDA
Jonathan Havens, Partner, Chair of Food & Beverage Practice, Co-Chair of Cannabis Law Practice, Saul Ewing Arnstein & Lehr LLP
Larry Houck, Director, Hyman, Phelps & McNamara, PC
Moderated by Bridget Dooling, Research Professor, George Washington University
On-demand webinar recordings are sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day of your purchase.